Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Tisagenlecleucel

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Gowling WLG (Canada) LLP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Gowling WLG (Canada) LLP

    TISAGENLECLEUCEL
    arrow
    ACI Convention
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    ACI Convention
    Not Confirmed

    Patent Expiration Date : 2031-12-09

    Date Granted : 2018-10-23

    TISAGENLECLEUCEL

    Brand Name : KYMRIAH

    Patent Number : 2820681

    Filing Date : 2011-12-09

    Strength per Unit : 1.2x10^6 to 6.0x10^8 CAR - positive viable T cells

    Dosage Form : SUSPENSION

    Human Or VET : Human

    Route of Administration : INTRAVENOUS

    Patent Expiration Date : 2031-12-09

    Date Granted : 2018-10-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Gowling WLG (Canada) LLP

    TISAGENLECLEUCEL
    arrow
    ACI Convention
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    ACI Convention
    Not Confirmed

    Patent Expiration Date : 2033-07-12

    Date Granted : 2023-03-14

    TISAGENLECLEUCEL

    Brand Name : KYMRIAH

    Patent Number : 2878928

    Filing Date : 2013-07-12

    Strength per Unit : 1.2x10^6 to 6.0x10^8 CAR - positive viable T cells

    Dosage Form : SUSPENSION

    Human Or VET : Human

    Route of Administration : INTRAVENOUS

    Patent Expiration Date : 2033-07-12

    Date Granted : 2023-03-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF